In a study where the salivary glands of 19 patients with primary SS and 16 patients with non-specific sialadenitis were biopsied by immunohistochemistry, IL-22 expression of patients with SS and the control group was increased (73). This evidence concerns the gene IL22 and synovial sarcoma.